Nick Saccomano

Nicholas A. Saccomano, Ph.D.

President
& Chief Executive Officer

Nicholas A. Saccomano, Ph.D.
Anthony D. Piscopio, Ph.D.

Anthony D. Piscopio, Ph.D.

Head of Research and Development

Anthony D. Piscopio, Ph.D.
Jim Winkler, Ph.D.

Jim Winkler, Ph.D.

Chief Scientific Officer

Jim Winkler, Ph.D.
Duncan Walker, Ph.D.

Duncan Walker, Ph.D.

Chief Development Officer

Duncan Walker, Ph.D.

Jason Leverone, CPA

Chief Financial Officer

Jason Leverone, CPA

Samuel Agresta, M.D.

Chief Medical Officer

Samuel Agresta, M.D.
Keith Olivia

Keith M. Olivia, J.D., LL.M.

General Counsel, Senior
Vice President of Corporate
Affairs & Secretary

Keith M. Olivia, J.D., LL.M.
James Blake, Ph.D.

James Blake, Ph.D.

Senior Vice President
of Computational Drug
Discovery

James Blake, Ph.D.

Kevin S. Litwiler, Ph.D.

Senior Vice President
of DMPK and Clinical
Pharmacology

Kevin S. Litwiler, Ph.D.
Richard Woessner, Ph.D.

Richard Woessner, Ph.D.

Senior Vice President
of Pharmacology

Richard Woessner, Ph.D.

Robbie Alton, Pharm

Vice President of Clinical Operations

Robbie Alton, Pharm

Mark L. Boys, Ph.D.

Senior Vice President of Discovery Chemistry

Mark L. Boys, Ph.D.

Ann Howell, Pharm.D.

Vice President of Regulatory Affairs

Ann Howell, Pharm.D.

Board of Directors

Isaac Manke, Ph.D.

Isaac Manke, Ph.D.

R. Michael Carruthers

R. Michael Carruthers

Nicholas A. Saccomano, Ph.D.

Nicholas A. Saccomano, Ph.D.

Andrew Phillips, Ph.D.

Andrew Phillips, Ph.D.

Investors

Acorn Bioadventures logo
Cormorant Asset Management logo
Deep Track Capital
Surveyer logo
Samsara Biocapital logo
Perceptive Advisors logo
Black Rock logo